| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |